跳至主要内容
临床试验/NCT06681506
NCT06681506招募中不适用

A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart Disease: a Prospective, Randomized Controlled Clinical Study

Shanghai 10th People's Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
Change from baseline myocardial infarct area at 6 months

研究概览

简要总结

Cardiac rehabilitation is an important link in cardiovascular disease. This study mainly explores the effectiveness of new cardiac rehabilitation therapy (early respiratory rehabilitation, phase I rehabilitation, exercise therapy, external counterpulsation, extracorporeal shock wave, etc.) on patients with ischemic heart disease such as coronary heart disease and heart failure, and the compliance of home rehabilitation compared with traditional cardiac rehabilitation therapy (traditional exercise rehabilitation, rehabilitation education, etc.).

详细描述

This study is a prospective, randomized, controlled study, follow the principle of PICOST design, specific as follows: Participants (the list) : preliminary clinical diagnosis of coronary atherosclerotic heart disease, heart failure. Intervention (Intervention) : conventional drug therapy + new cardiac rehabilitation therapy, a new cardiac rehabilitation treatment reference guide requirements, according to the actual circumstance of patients treated with 1-3 months Intervention. Comparator(control): conventional drug therapy + traditional cardiac rehabilitation therapy. The traditional cardiac rehabilitation therapy referred to domestic and international guidelines and consensus, and used 1 week-3 months of treatment intervention according to the actual situation of patients. Outcome (the end) : the primary end point: D_SPECT examination, were followed up for 6 months to evaluate myocardial perfusion imaging is reduce ischemic area. The secondary end point: 1) the blood biochemical examination and myocardial necrosis markers, etc.; 2) the cardiopulmonary exercise testing: maximum kilograms oxygen uptake and anaerobic threshold when the maximum kilograms oxygen uptake; 3) the major adverse cardiovascular events: cardioascular death, non-fatal myocardial infarction, unplanned coronary artery reconstruction, stroke, heart failure and angina associated hospitalized again; 4) patients family rehabilitation treatment adherence

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Care Provider)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 18 and 85 years old
  • Female subjects no pregnancy
  • The main admission diagnosis of ischemic heart disease (coronary heart disease, myocardial infarction, ischemic heart failure, etc.)
  • The need for cardiac rehabilitation treatment

排除标准

  • acute respiratory distress syndrome (ARDS);
  • acute episode of COPD;
  • uncontrolled pulmonary infection;
  • acute heart failure; acute pulmonary embolism;
  • acute myocarditis/pericarditis;
  • severe arrhythmia (degree II or III atrioventricular block, atrial flutter, or atrial fibrillation);
  • sternotomy, rib fracture, thoracic deformity, or other neurological diseases that may affect respiratory muscles

结局指标

主要结局

Change from baseline myocardial infarct area at 6 months

时间窗: 1 day of inclusions and 6 months after the first treatment.

The location and extent of myocardial infarction were determined by D-SPECT.

次要结局

  • 6 months hemodynamic changes in relative to the baseline(1 day of inclusions and 6 months after the first treatment.)
  • Change from baseline peak oxygen consumption at 6 months(1 day of inclusions and 6 months after the first treatment.)

研究者

发起方
Shanghai 10th People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ya-Wei Xu

Chief Physician

Shanghai 10th People's Hospital

研究点 (1)

Loading locations...

相似试验

A New Cardiac Rehabilitation Treatment in the... | 临床试验